Scoping review finds that artificial intelligence interventions for dementia remain in early feasibility stages, highlighting the need for rigorous clinical validation before real-world adoption.
This review highlights that AI applications for enhancing QoL in people with dementia are still in early development, with research largely limited to small-scale feasibility studies rather than demonstrating clinical effectiveness. While AI holds promise, further exploration and rigorous real-world validation are needed before AI can meaningfully impact the daily lives of people with dementia.
No takes yet. Share an insight, caveat, or question.
Steijger et al. (2025) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: